Berta Ponsati Obiols

Title: Berta Ponsati Obiols: Innovator in Peptide Therapeutics

Introduction

Berta Ponsati Obiols is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of peptide therapeutics, holding a total of eight patents. Her work focuses on developing innovative treatments for various medical conditions, particularly inflammatory and immune diseases.

Latest Patents

Among her latest patents, Berta has developed cortistatin analogues aimed at treating inflammatory and immune diseases. This invention relates to peptide ligands that can be used in the diagnosis, prevention, or therapy of conditions where cortistatin receptors are expressed. These compounds are designed to be more stable in serum compared to natural cortistatin. Another notable patent involves bicalutamide analogs, which serve as exocytosis activating compounds for treating lysosomal storage disorders or glycogenosis. This invention provides a novel therapy that promotes lysosomal exocytosis, thereby reducing the accumulation of toxic substrates in affected cells.

Career Highlights

Berta has worked with several companies, including Bcn Peptides S.A. and Lipotec S.A. Her experience in these organizations has allowed her to advance her research and contribute to the development of therapeutic solutions in the peptide domain.

Collaborations

Berta has collaborated with notable colleagues such as Gemma Jodas Farres and Jimena Fernández Carneado. These partnerships have enriched her research and expanded the impact of her innovations in the field.

Conclusion

Berta Ponsati Obiols is a trailblazer in peptide therapeutics, with a strong portfolio of patents that address critical health challenges. Her innovative work continues to pave the way for new treatment options in medicine.